| 000 | 01297 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513235538.0 | ||
| 264 | 0 | _c20010705 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a1052-5157 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPiñeiro-Carrero, V M | |
| 245 | 0 | 0 |
_aEtiology and treatment of achalasia in the pediatric age group. _h[electronic resource] |
| 260 |
_bGastrointestinal endoscopy clinics of North America _cApr 2001 |
||
| 300 |
_a387-408, viii p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aBotulinum Toxins, Type A _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 | _aDilatation |
| 650 | 0 | 4 |
_aEsophageal Achalasia _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle, Smooth _xsurgery |
| 650 | 0 | 4 |
_aNeuromuscular Agents _xtherapeutic use |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 |
_aPediatrics _xmethods |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSullivan, C A | |
| 700 | 1 | _aRogers, P L | |
| 773 | 0 |
_tGastrointestinal endoscopy clinics of North America _gvol. 11 _gno. 2 _gp. 387-408, viii |
|
| 999 |
_c11253254 _d11253254 |
||